Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Novus Biologicals™ ERK2 Knockout A549 Cell Lysate
Cell Lysate
Supplier: Novus Biologicals™ NBP318632
Specifications
P28482, P28482, P28482, P28482 | |
100 μg | |
Human | |
Angiogenesis, Apoptosis, Breast Cancer, Cancer, Diabetes Research, Hypoxia, Phospho Specific, Protein Kinase, Signal Transduction, Tumor Suppressors | |
EC 2.7.11, EC 2.7.11.24, ERK, ERK-2, ERK2MAP kinase isoform p42, ERT1, Extracellular signal-regulated kinase 2, MAP kinase 1, MAP kinase 2, MAPK 1, MAPK2, mitogen-activated protein kinase 1, Mitogen-activated protein kinase 2, p38, p40, p41, p41mapk, p42-MAPK, P42MAPK, PRKM1MAPK 2, PRKM2, protein tyrosine kinase ERK2 |
This product has been tested by SDS-PAGE and western blot and is suitable for use in Western blot, ELISA, Immunoprecipitation and ChIP. No detection of expected band at ~44 kDa is observed in MAPK1 (ERK2) knockout A549 when compared with unmodified A549 cell lysates by Western blot. | |
Multi-step | |
Store at -70°C. Avoid freeze/thaw cycles. | |
ERK2 | |
MAPK1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction